Increased myopia linked to higher education levels

Article

Attaining a higher level of education and spending more years in school are associated with a greater prevalence and severity of myopia, according to a new study published online.

Attaining a higher level of education and spending more years in school are associated with a greater prevalence and severity of myopia, according to a study published online in Ophthalmology.

Researchers at the University Medical Center in Mainz, Germany, conducted a population-based, cross-sectional study of a cohort of the Gutenberg Health Study. They studied the incidence of myopia in 4,658 Germans ages 35 to 74, excluding anyone with cataracts or who had undergone refractive surgery, and found that myopia appeared to become more prevalent as education level increased.

Among the findings:

  • 24% of individuals who had no high school education or other training were nearsighted.

  • 35% of high school graduates and vocational school graduates were nearsighted.

  • 53% of university graduates were nearsighted.

In addition to education levels completed, the researchers also found that people who spent more years in school were more severely myopic, with the degree of myopia worsening for each year of school. Furthermore, the researchers looked at the effect of 45 genetic markers, but found genetics to be a much weaker factor in the degree of myopia compared to education level.

To read the study, click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.